These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7107522)

  • 1. Effects of N-alkylation and n-acylation on tobramycin activity.
    Sicsic S; Le Bigot JF; Vincent C; Cerceau C; Le Goffic F
    J Antibiot (Tokyo); 1982 May; 35(5):574-9. PubMed ID: 7107522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Singly modified amikacin and tobramycin derivatives show increased rRNA A-site binding and higher potency against resistant bacteria.
    Fair RJ; McCoy LS; Hensler ME; Aguilar B; Nizet V; Tor Y
    ChemMedChem; 2014 Sep; 9(9):2164-71. PubMed ID: 25055981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance.
    Shaul P; Green KD; Rutenberg R; Kramer M; Berkov-Zrihen Y; Breiner-Goldstein E; Garneau-Tsodikova S; Fridman M
    Org Biomol Chem; 2011 Jun; 9(11):4057-63. PubMed ID: 21365081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C; Crevatin E
    Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
    Melby K; Midtvedt T; Dahl O
    Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory findings of tobramycin and their relation to clinical response.
    McAllister TA; Tait SC
    J Infect Dis; 1976 Aug; 134 Suppl():S20-7. PubMed ID: 823277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synergy of cefazolin-tobramycin against gram-positive bacteria.
    Collins RF; Edwards LD
    J Antimicrob Chemother; 1980 May; 6(3):323-31. PubMed ID: 7400067
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on disc method for tobramycin sensitivity test (author's transl)].
    Kanazawa Y; Kuramata T; Matsumoto K; Hoshida F
    Jpn J Antibiot; 1979 Oct; 32(10):1003-8. PubMed ID: 513281
    [No Abstract]   [Full Text] [Related]  

  • 11. [In-vitro antimicrobial activity of 2 aminoglycoside antibiotics: tobramycin and gentamycin].
    Ceddia T; Mancini A; Marinucci MC
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):534-7. PubMed ID: 550883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.
    Moellering RC; Wennersten C; Kunz LJ; Poitras JW
    Am J Med; 1977 Jun; 62(6):873-81. PubMed ID: 868901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacterial resistance to aminoglycoside antibiotics].
    Kettner M; Macicková T
    Bratisl Lek Listy; 1992 Apr; 93(4):175-8. PubMed ID: 1393633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory and clinical evaluation of tobramycin, a new aminoglycoside antibiotic.
    Escárzaga E; Hill J; Ganzález S; Berruecos P; Luna M; Gutiérrez M
    J Infect Dis; 1976 Aug; 134 Suppl():S158-64. PubMed ID: 972275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of LY 146032, a novel cyclic lipopeptide, alone and in combination with gentamicin or tobramycin against enterococci.
    Watanakunakorn C
    J Antimicrob Chemother; 1987 Apr; 19(4):445-8. PubMed ID: 3034849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituted amines synergistic with tobramycin against Burkholderia cepacia in vitro.
    Cohn RC; Rudzienski L
    Chemotherapy; 1997; 43(2):100-7. PubMed ID: 9084918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of inhibitory (MIC) and subinhibitory concentrations of tobramycin on bacteriostatic and bactericidal activities of beta-lactam antibiotics (author's transl)].
    Masuda G; Yajima T; Nakamura K; Yanagishita T; Yamazaki E
    Jpn J Antibiot; 1979 Nov; 32(11):1189-95. PubMed ID: 117156
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro studies of tobramycin sensitivity of bacterial strains isolated from children treated in the Institute for Mother and Child].
    Duroś H; Nowakowska K
    Probl Med Wieku Rozwoj; 1982; 11():117-20. PubMed ID: 6817325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.